Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models-Reference-Cited by-同舟云学术

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models

Published:2014-09-10 Issue:1 Volume:9 Page:323-333
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Gavine Paul R.,Ren Yongxin,Han Lu,Lv Jing,Fan Shiming,Zhang Wei,Xu Wen,Liu Yuan Jie,Zhang Tianwei,Fu Haihua,Yu Yongjuan,Wang Huiying,Xu Shirlian,Zhou Feng,Su Xinying,Yin XiaoLu,Xie Liang,Wang Linfang,Qing Weiguo,Jiao Longxian,Su Weiguo,Wang Q. May

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference41 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

2. Met, metastasis, motility and more;Birchmeier;Nat. Rev. Mol. Cell Biol,2003

3. Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence;Catenacci;Cancer Discov,2011

4. Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1 -yl)ethanol (PF-04217903) for the treatment of cancer;Cui;J. Med. Chem,2012

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling promising targets in gastric cancer therapy: A comprehensive review;Molecular Therapy: Oncology;2024-09

2. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review;World Journal of Gastrointestinal Oncology;2024-08-15

3. Ferroptosis regulating lipid peroxidation metabolism in the occurrence and development of gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

4. Characterization of MET Alterations in 37 Gastroesophageal Cancer Cell Lines for MET-Targeted Therapy;International Journal of Molecular Sciences;2024-05-29

5. Advances in MET tyrosine kinase inhibitors in gastric cancer;Cancer Biology & Medicine;2024-05-10